investorscraft@gmail.com

Intrinsic Value of Champions Oncology, Inc. (CSBR)

Previous Close$5.68
Intrinsic Value
Upside potential
Previous Close
$5.68

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2023-04-30 and quarterly data as of 2023-07-31.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2024202520262027202820292030203120322033203420352036203720382039204020412042204320442045204620472048

INCOME STATEMENT

Revenue growth rate, %9.7NaN
Revenue, $54NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m59NaN
Operating income, $m-5NaN
EBITDA, $m-3NaN
Interest expense (income), $mNaN
Earnings before tax, $m-5NaN
Tax expense, $m0NaN
Net income, $m-5NaN

BALANCE SHEET

Cash and short-term investments, $m10NaN
Total assets, $m34NaN
Adjusted assets (=assets-cash), $m24NaN
Average production assets, $m7NaN
Working capital, $m-2NaN
Total debt, $m9NaN
Total liabilities, $m30NaN
Total equity, $m5NaN
Debt-to-equity ratio1.855NaN
Adjusted equity ratio-0.177NaN

CASH FLOW

Net income, $m-5NaN
Depreciation, amort., depletion, $m2NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m4NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-3NaN
Free cash flow, $m7NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m-2
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount